You've wasted no time at all, I think most LTHs are obviously confident but we have no reason not to be. The company is launching a hassle free, no fuss product with a great safety profile... We believe in management to launch it the right way as they have done with many other drugs.
Are there risks? Absolutely, but much less than we had before approval.
Your thoughts are welcome and read by many of us. Cheers
You've wasted no time at all, I think most LTHs are obviously...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 32.5¢ | 31.5¢ | $1.940M | 6.061M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 470483 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 33000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |